Hepatitis C Drugs Boost the Antiviral Activity of Remdesivir Against COVID-19
Professor Gaetano Montelione's team found that several hepatitis C drugs blocked replication of the COVID virus in lab-grown cells, and some made remdesivir work markedly better.